Breaking News Instant updates and real-time market news.

AMGN

Amgen

$194.23

1.83 (0.95%)

12:51
11/17/18
11/17
12:51
11/17/18
12:51

Amgen may be 'a remedy' for tougher times, Barron's says

Amgen may be a stock that gives investors "a break from worrying about all the things that could go wrong with the global economy," Al Root writes in this week's edition of Barron's. Valued at $123B, Amgen trades for about 13 times estimated earnings and generates over $10B in free cash flow annually, the report notes, adding that while the company faces competition from new biosimilars, it seems a lot of fear is already reflected in the stock price. Reference Link

  • 27

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

AMGN Amgen
$194.23

1.83 (0.95%)

10/31/18
RBCM
10/31/18
NO CHANGE
Target $182
RBCM
Sector Perform
Amgen price target lowered to $182 from $193 at RBC Capital
RBC Capital analyst Kennen MacKay lowered his price target on Amgen to $182 and kept his Sector Perform rating after its Q3 results. The analyst says the quarter was "in line" with "safe" expectations, even as the company's core business competition is "slow" to impact sales. MacKay further cites an "astonishing" launch of Aimovig with 100K new patients, but also notes the sales decline against sequential volume growth for Amgen's Repatha.
10/29/18
PIPR
10/29/18
NO CHANGE
PIPR
Neutral
Piper sees Amgen's Aimovig pressuring Allergan's Botox in near term
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Amgen (AMGN) and Neutral rating on Allergan (AGN) after his firm's Overweight based on feedback from a migraine survey fielded by his firm's partner Spherix Global Insights. The analyst is "struck by the progress" Amgen has made just months into Aimovig's launch, specifically on sales coverage, message delivery and overall credibility with physicians. It appears that Allergan's Botox "could be in for some pressure in the near term at the direct hands" of Amgen's Aimovig, Raymond tells investors in a research note titled "Aiming for Aimovig; New Migraine Survey Indicates Aimovig the Star of the Show." Doctors are projecting peak Aimovig share of 49% and 29% for chronic and episodic patients respectively, which infers peak U.S. revenue for the drug at $3.3B, the analyst says. Further, he notes that of the 98 high volume migraine specialists surveyed, 43% versus 29% agreed with the statement: "I am more likely to prescribe Aimovig over Botox due to access to patient assistance program."
10/25/18
MSCO
10/25/18
NO CHANGE
Target $212
MSCO
Overweight
Repatha list price cut has benefits for Amgen, says Morgan Stanley
Morgan Stanley analyst Matthew Harrison noted that Amgen announced that it is reducing Repatha's list price by 60%, stating that he believes the new list price of $5,850/year is similar to the current net price for the treatment. He also noted that Amgen management said they anticipate little impact to long-term blended net price, though there could be some volatility in the near-term. Given the current political environment, he sees two key benefits to the strategy, namely that it is "a novel SKU strategy" and second the lower price likely improves a structural headwind since Repatha is largely a Medicare product. Harrison keeps an Overweight rating on Amgen shares.
10/01/18
CANT
10/01/18
INITIATION
Target $223
CANT
Neutral
Amgen initiated with a Neutral at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young started Amgen with a Neutral rating and $223 price target.

TODAY'S FREE FLY STORIES

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

AUTL

Autolus Therapeutics

$26.67

0.09 (0.34%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Hot Stocks
Autolus Therapeutics receives orphan drug designation for enriched T-cells »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

MDSO

Medidata

$90.30

11.44 (14.51%)

, DASTY

Dassault Systemes

$0.00

(0.00%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Downgrade
Medidata, Dassault Systemes rating change  »

Medidata downgraded to…

MDSO

Medidata

$90.30

11.44 (14.51%)

DASTY

Dassault Systemes

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 23

    Jun

AZRX

AzurRx BioPharma

$2.60

0.185 (7.68%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
AzurRx BioPharma surpasses 50% enrollment for Phase 2 OPTION study »

AzurRx BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HAL

Halliburton

$31.09

-0.03 (-0.10%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Recommendations
Halliburton analyst commentary at SunTrust »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 15

    May

  • 22

    May

  • 29

    May

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
JetBlue sees Q2 effective tax rate of approx. 25% »

JetBlue expects an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

ACHC

Acadia

$29.66

0.16 (0.54%)

07:49
04/23/19
04/23
07:49
04/23/19
07:49
Recommendations
Acadia analyst commentary  »

Citi opens 'Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

PAG

Penske Automotive

$44.64

-1.305 (-2.84%)

07:48
04/23/19
04/23
07:48
04/23/19
07:48
Conference/Events
Penske Automotive management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 09

    May

  • 14

    May

  • 15

    May

  • 28

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
JetBlue says 'on track' to hit 2018-2020 CASM CAGR goal of 0-1% growth »

Says executing on plan to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

JEC

Jacobs Engineering

$78.69

1.755 (2.28%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
Jacobs Engineering extends contract with Watercare »

Jacobs has secured a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

PRIM

Primoris

$22.00

0.14 (0.64%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
Primoris announces natural gas distribution awards with value over $25M »

Primoris announced three…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

PACW

PacWest Bancorp

$38.85

-0.39 (-0.99%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Conference/Events
PacWest Bancorp management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 13

    May

ISRG

Intuitive Surgical

$490.70

-37.34 (-7.07%)

07:46
04/23/19
04/23
07:46
04/23/19
07:46
Recommendations
Intuitive Surgical analyst commentary at Citi »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

NVR

NVR

$3,260.82

173.72 (5.63%)

07:45
04/23/19
04/23
07:45
04/23/19
07:45
Recommendations
NVR analyst commentary  »

NVR price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

LMT

Lockheed Martin

$315.24

0.94 (0.30%)

07:45
04/23/19
04/23
07:45
04/23/19
07:45
Hot Stocks
Breaking Hot Stocks news story on Lockheed Martin »

Lockheed Martin up 6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 29

    May

  • 05

    Jun

CVE

Cenovus Energy

$10.43

0.345 (3.42%)

07:45
04/23/19
04/23
07:45
04/23/19
07:45
Recommendations
Cenovus Energy analyst commentary at Citi »

Citi opens '30-Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

NUE

Nucor

$57.00

-0.495 (-0.86%)

07:43
04/23/19
04/23
07:43
04/23/19
07:43
Hot Stocks
Nucor CEO says 'well-positioned for continued growth and success' »

"Our diversified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 09

    May

ZTO

ZTO Express

$19.30

-0.3 (-1.53%)

07:43
04/23/19
04/23
07:43
04/23/19
07:43
Upgrade
ZTO Express rating change  »

ZTO Express upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

DLR

Digital Realty

$119.37

-1.06 (-0.88%)

07:43
04/23/19
04/23
07:43
04/23/19
07:43
Downgrade
Digital Realty rating change at Jefferies »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 13

    May

  • 04

    Jun

  • 18

    Jun

WSO

Watsco

$150.99

-0.39 (-0.26%)

07:42
04/23/19
04/23
07:42
04/23/19
07:42
Earnings
Watsco reports Q1 EPS 88c, consensus 88c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

TWTR

Twitter

$34.39

-0.01 (-0.03%)

07:42
04/23/19
04/23
07:42
04/23/19
07:42
Hot Stocks
Twitter sees FY19 CapEx $550M-$600M »

Sees GAAP operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

STAG

STAG Industrial

$28.47

-0.405 (-1.40%)

07:42
04/23/19
04/23
07:42
04/23/19
07:42
Initiation
STAG Industrial initiated  »

STAG Industrial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 01

    May

FCPT

Four Corners Property Trust

$27.75

-0.42 (-1.49%)

07:41
04/23/19
04/23
07:41
04/23/19
07:41
Initiation
Four Corners Property Trust initiated  »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

HBCP

Home Bancorp

$36.30

-0.67 (-1.81%)

07:41
04/23/19
04/23
07:41
04/23/19
07:41
Hot Stocks
Home Bancorp raises dividend 5% to 21c »

The Company increased its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

TWTR

Twitter

$34.39

-0.01 (-0.03%)

07:41
04/23/19
04/23
07:41
04/23/19
07:41
Hot Stocks
Twitter says total headcount at end of Q1 reached more than 4,100 employees »

Total headcount at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.